Article Abstract

The superiority of robot in surgery of mediastinal diseases

Authors: Giuseppe Marulli


Since 2001, when robotic technology was first approved by the US Food and Drug Administration (FDA) (1) and then introduced in clinical practice, the best targets for cardio-thoracic surgery were considered all those procedures requiring operating in tiny and/or difficult to reach spaces, where an extreme dexterity an precision of instruments are required (2).